In this interview, we spoke to Yoav Golan about recent developments in the field of Clostridium difficile infections – from the latest clinical trial results to newly updated guidelines.
Browsing: Clinical Management
In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
In this interview, we speak to to Keith Kaye, Principle Investigator of the RESTORE-1 trial assessing relebactam in combination with imipenem (IMI/REL), about the trial’s results and the implications these have for clinicians in ‘real world’ settings.
Nearly half of prescriptions for antibiotics were written without an infection-related diagnosis, according to a study of 509,534 prescriptions reported at IDWeek today.
A Phase III study, TANGO II, has reported that meropenem–vaborbactam monotherapy for CRE infections was associated with improvement in clinical cure rates, lower nephrotoxicity and lower mortality versus best-available therapy.
A study using standardized patients has reported that private practitioners in India are delivering a wide range of often inadequate care to tuberculosis patients.
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
International Nurses Day: A day in the life of… Helen Bosley, Infection Prevention and Control Matron
To celebrate International Nurses Day we spoke to Helen Bosley, Infection Prevention and Control Matron at Oxford Health NHS Foundation Trust about her responsibilities, her daily routine and her hobbies.
International Nurses Day: A day in the life of… Leila Hail, Senior Clinical Nurse Specialist in Infection Control
With May 12 marking International Nurses Day we spoke to Leila Hail, Senior Clinical Nurse Specialist in Infection Control at University College Hospital, about her responsibilities, the challenges she faces and an incident involving alcohol gel!
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.